Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 21.48 USD 1.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Catalyst Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Catalyst Pharmaceuticals Inc

Current Assets 474.4m
Cash & Short-Term Investments 375.7m
Receivables 57.2m
Other Current Assets 41.6m
Non-Current Assets 231.9m
Long-Term Investments 13.1m
PP&E 3.6m
Intangibles 175.4m
Other Non-Current Assets 39.9m
Current Liabilities 92.3m
Accounts Payable 7.1m
Accrued Liabilities 72.9m
Other Current Liabilities 12.3m
Non-Current Liabilities 5.4m
Other Non-Current Liabilities 5.4m

Balance Sheet
Catalyst Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
9
28
14
58
17
90
130
171
298
138
Cash Equivalents
9
28
14
58
17
90
130
171
298
138
Short-Term Investments
30
30
27
27
37
5
10
20
0
0
Total Receivables
0
0
0
0
0
11
6
7
10
54
Accounts Receivables
0
0
0
0
0
11
6
7
10
54
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
2
5
8
7
16
Other Current Assets
5
2
1
1
2
4
8
4
5
13
Total Current Assets
44
60
42
85
55
111
159
210
321
219
PP&E Net
0
0
0
0
0
1
0
4
4
4
PP&E Gross
0
0
0
0
0
0
0
4
4
4
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
1
Intangible Assets
0
0
0
0
0
0
0
0
33
194
Long-Term Investments
0
0
0
0
5
0
0
0
0
16
Other Long-Term Assets
0
0
0
0
0
0
33
24
19
37
Total Assets
44
N/A
60
+37%
42
-31%
85
+105%
60
-29%
112
+86%
192
+71%
238
+24%
376
+58%
470
+25%
Liabilities
Accounts Payable
2
2
1
2
2
4
4
3
4
15
Accrued Liabilities
4
2
1
2
7
17
18
24
32
48
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
3
0
0
22
14
Total Current Liabilities
6
3
2
4
10
24
23
27
58
76
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
3
1
0
0
0
1
0
4
18
6
Total Liabilities
9
N/A
5
-47%
2
-48%
4
+83%
10
+120%
25
+155%
23
-8%
31
+36%
75
+143%
82
+9%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
70
90
108
127
161
129
54
26
50
121
Additional Paid In Capital
105
146
147
207
211
216
223
233
250
266
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
35
N/A
56
+58%
39
-29%
81
+106%
51
-37%
88
+72%
170
+94%
207
+22%
300
+45%
388
+29%
Total Liabilities & Equity
44
N/A
60
+37%
42
-31%
85
+105%
60
-29%
112
+86%
192
+71%
238
+24%
376
+58%
470
+25%
Shares Outstanding
Common Shares Outstanding
69
83
83
103
103
103
104
103
105
107

See Also

Discover More